نتایج جستجو برای: warfarin dose

تعداد نتایج: 318316  

تاجیک, علیرضا, سهرابی, محمد کریم,

Background: Warfarin is one of the most common oral anticoagulant, which role is to prevent the clots. The dose of this medicine is very important because changes can be dangerous for patients. Diagnosis is difficult for physicians because increase and decrease in use of warfarin is so dangerous for patients. Identifying the clinical and genetic features involved in determining dose could be us...

A high prevalence of genetic polymorphisms increases sensitivity to warfarin therapy. In this study, we investigated 47 patients with effective long-term therapy by warfarin well-controlled by monitoring of International Normalised Ratio (INR). All patients were tested for gene polymorphisms VKORC1, CYP2C9*C2, and CYP2C9*C3, which were used for a dose calculation employing a program www.Warfari...

صدرعاملی, محمدعلی , عرب‌علی‌بیک, حسین , قائم‌پناه, زهرا , قاضی سعیدی, مرجان ,

Background: Warfarin is the most common oral anticoagulant. This drug is used for the prevention and treatment of thromboembolic patients. It is difficult for physician to predict the results of warfarin prescriptions because there is narrow boundary between therapeutic range and complications of warfarin. Therefore drug dose adjustment is normally performed by an expert physician. Decision sup...

Journal: :international journal of hematology-oncology and stem cell research 0
behzad poopak dcls,phd in hematology, islamic azad university, tehran medical sciences branch, tehran, iran saghar rabieipoor msc in biotechnology, payvand clinical and specialty laboratory, tehran, iran nazila safari msc in molecular oncology, payvand clinical and specialty laboratory, tehran, iran emadedin naraghi msc in bioscience, payvand clinical and specialty laboratory, tehran, iran fatemeh sheikhsofla msc in cell and molecular biology, payvand clinical and specialty laboratory, tehran, iran gelareh khosravipoor md, payvand clinical and specialty laboratory, tehran, iran 4msc in bioscience, payvand clinical and specialty laboratory, tehran, iran

background: although catalytic properties of different genetic polymorphisms of vkorc1 and cyp2c9 products have been identified, there is limited study available regarding warfarin dose requirement in iranian patient population. this study investigates the impact of these polymorphisms on 115 patients, referred to payvand clinical and specialty laboratory for determining the appropriate dose of...

ژورنال: پیاورد سلامت 2018
آقازاده, مریم, اروجی, اعظم, قاضی سعیدی, مرجان, لنگری زاده, مصطفی, مقبلی, فاطمه, کامکار حقیقی, مهران,

Background and Aim: Artificial intelligence is a branch of computer science that has the ability of analyzing complex medical data. Using artificial intelligence is common in diagnosing, treating and taking care of patients. Warfarin is one of the most commonly prescribed oral anticoagulants. Determining the exact dose of warfarin needed for patients is one of the major challenges in the health...

A high prevalence of genetic polymorphisms increases sensitivity to warfarin therapy. In this study, we investigated 47 patients with effective long-term therapy by warfarin well-controlled by monitoring of International Normalised Ratio (INR). All patients were tested for gene polymorphisms VKORC1, CYP2C9*C2, and CYP2C9*C3, which were used for a dose calculation employing a program www.Warfari...

The requirement of varying doses of warfarin for different individuals can be explained by environmental and genetic factors. We evaluated the frequency of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP2C9) variants together with patientdemographic characteristics and investigated their association with warfarin dose requirement with the ob...

2012
MingSong Wang XiLong Lang ShiTao Cui Ke Fei LiangJian Zou Jia Cao LiangXu Wang ShengHui Zhang XinTian Wu YiLing Wang Qiang Ji

BACKGROUND The polymorphisms of VKORC1 and CYP2C9 play increasingly important roles in the inter-individual variability in warfarin dose. This study aimed to evaluate the feasibility of clinical application of pharmacogenetic-based warfarin-dosing algorithm in patients of Han nationality with rheumatic heart disease after valve replacement in a randomized and controlled trial. METHODS One hun...

Background and Aims: Warfarin is an anticoagulant agent used for many years in treating various clinical conditions such as thromboembolisms in cardiovascular disease. Some patients require different doses of warfarin to reach the therapeutic international normalized ratio ratio. These patients have specific demographic characteristics. Genetic polymorphisms in specific genes have been reported...

The requirement of varying doses of warfarin for different individuals can be explained by environmental and genetic factors. We evaluated the frequency of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP2C9) variants together with patientdemographic characteristics and investigated their association with warfarin dose requirement with the ob...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید